Streetbeat News

Stock Prices

AMZN

CHWY

WMT

Chewy, Inc. (NYSE:CHWY) reported strong Q1 2024 results, surpassing expectations with an adjusted EPS of $0.31 and sales of $2.88 billion. Analysts have raised their price targets and remain optimistic about the company's future growth and profitability.

Portfolio Pulse from Nabaparna Bhattacharya

May 30, 2024 | 6:47 pm

SPG

Recent options trading activity for Simon Property Group (NYSE:SPG) indicates a bearish sentiment among large investors, with 6 put options and 2 call options detected. The price target for SPG is between $125.0 and $155.0. The stock is currently trading at $148.07, up by 0.66%, with an RSI indicating it may be approaching overbought territory. An analyst from Scotiabank maintains a Sector Perform rating with a price target of $152.0.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 6:45 pm

DIS

PEP

PG

SPY

Activist investor Nelson Peltz, through Trian Fund Management, increased his stake in Walt Disney Co (NYSE:DIS) last October and owned more than 1% by the end of 2023. Despite losing a proxy battle to oust CEO Bob Iger, Peltz sold his entire Disney stake for nearly $1 billion. Disney's stock has outperformed the SPDR S&P 500 Trust (NYSE:SPY) in 2024, although it dropped 10% on May 7. Peltz has previously taken activist positions in companies like Proctor & Gamble Co (NYSE:PG) and PepsiCo (NYSE:PEP).

Portfolio Pulse from Aaron Bry

May 30, 2024 | 6:43 pm

SMMT

Summit Therapeutics shares are trading higher after the company's Phase III HARMONi-2 trial met its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 6:40 pm

PSTG

Pure Storage, Inc. (NYSE:PSTG) shares are trading higher following the company's quarterly earnings announcement. The company reported better-than-expected adjusted EPS and sales for Q1 of fiscal-year 2025 and issued positive guidance for Q2 and the full fiscal year. Several analysts have raised their price targets for the stock.

Portfolio Pulse from Dylan Berman

May 30, 2024 | 6:39 pm

HRL

Hormel Foods shares are trading lower following Q2 earnings. The stock initially gained but has reversed.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 6:33 pm

MRK

SMMT

Summit Therapeutics announced that its Phase III trial HARMONi-2 met the primary endpoint of progression-free survival (PFS) for Ivonescimab in advanced NSCLC with PD-L1 expression. Ivonescimab is the first drug to show a clinically meaningful benefit over Pembrolizumab in a randomized Phase III clinical trial for NSCLC. The full data set will be presented at a major medical conference later this year.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 6:31 pm

PFE

Investors have taken a predominantly bearish stance on Pfizer (NYSE:PFE) as observed through recent options trading activity. Benzinga's options scanner detected 10 significant trades, with 90% of the sentiment being bearish. The trades suggest a targeted price range of $20.0 to $30.0 for Pfizer over the next few months. Analysts have mixed ratings, with price targets ranging from $29 to $36.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 6:31 pm

CAT

Caterpillar (NYSE:CAT) has outperformed the market over the past 10 years with an average annual return of 12.57%, surpassing the market by 2.07% annually. A $1000 investment in CAT 10 years ago would be worth $3,262.32 today.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 6:30 pm

ATI

ATI (NYSE:ATI) has significantly outperformed the market over the past 5 years, delivering an average annual return of 20.82%. A $1000 investment in ATI 5 years ago would be worth $2,768.67 today. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

May 30, 2024 | 6:30 pm